Latest Breaking News On - Roopal thakkar - Page 1 : comparemela.com

FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older

The FDA has expanded the indication of Rinvoq to include active, polyarticular juvenile idiopathic arthritis and psoriatic arthritis in children aged 2 years and older, according to an AbbVie press release. The announcement represents the first indication of Rinvoq (upadacitinib, AbbVie) for pediatric patients aged 2 years and older, the company said. To use the drug under the new indication,

United statesAarat patelShenaz baghaRoopal thakkarBon secours rheumatology center

AbbVie shares positive results for Rinvoq in head-to-head atopic dermatitis study

AbbVie shares positive results for Rinvoq in head-to-head atopic dermatitis study
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Regeneron sanofi dupixentJonathan silverbergAbbvie rinvoqRoopal thakkarGeorge washington university school of medicineHealth sciencesGeorge washington university school

Head-to-head, it s AbbVie s Rinvoq over Regeneron s Dupixent

Head-to-head, it s AbbVie s Rinvoq over Regeneron s Dupixent
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Jonathan silverbergRoopal thakkarAbbvie rinvoqJosh schimmerHealth sciencesGeorge washington university school of medicineEczema areaSeverity indexWorst pruritis numerical rating scaleGeorge washington university school

AbbVie (ABBV) Q1 2024 Earnings Call Transcript

ABBV earnings call for the period ending March 31, 2024.

Chris schottTim andersonRedburn atlanticTerence flynnTrung huynhRoopal thakkarLandos biopharmaSteve scalaCosentyx taltzChris shibutani goldman sachsGary nachman raymond jamesCarter gouldSimon bakerChris schott jpmorganGary nachmanCarrie strom

AbbVie JAK inhibitor shows potential in atopic dermatitis trial

AbbVie JAK inhibitor shows potential in atopic dermatitis trial
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Jonathan silverbergRoopal thakkarClinical researchGeorge washington university school of medicineHealth sciencesSenior vice presidentChief medical officerGlobal therapeuticsGeorge washington university schoolEczema areaSeverity indexWorst pruritus numerical rating scale